|Bid||0.0000 x 1200|
|Ask||0.0000 x 3000|
|Day's Range||3.4200 - 3.7200|
|52 Week Range||1.6200 - 9.8500|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 18, 2021 - Feb 22, 2021|
|Forward Dividend & Yield||0.28 (7.78%)|
|Ex-Dividend Date||Nov 13, 2020|
|1y Target Est||3.69|
Shares of movie theater stocks, including AMC Entertainment Holdings (NYSE: AMC), Cinemark Holdings (NYSE: CNK), and National CineMedia (NASDAQ: NCMI) all rose today after Moderna announced positive phase 3 results for its coronavirus vaccine. The biotech company said this morning that its coronavirus vaccine had a 94.5% efficacy rate in late-stage trials on a pool of more than 30,000 participants. The news follows last week's announcement from Pfizer and BioNTech that their coronavirus vaccine was successful in over 90% of participants in phase 3 trials.
Forget about who's president, the big news for theater operators was vaccine-related. But is the news really that good?
Before we get started, I would like to remind our listeners that this conference call contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All statements, including our discussion about the future impacts of COVID-19, other than statements of historical facts communicated during this conference call may constitute forward-looking statements.